Zimmer Biomet (ZBH) Competitors

Zimmer Biomet (NYSE:ZBH) and Penumbra (NYSE:PEN) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Do insiders and institutionals believe in ZBH or PEN?

88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 1.4% of Zimmer Biomet shares are owned by insiders. Comparatively, 4.2% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Do analysts recommend ZBH or PEN?

Zimmer Biomet presently has a consensus target price of $111.00, indicating a potential upside of 10.01%. Penumbra has a consensus target price of $302.93, indicating a potential upside of 14.93%. Given Penumbra's stronger consensus rating and higher probable upside, analysts clearly believe Penumbra is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	2 Sell rating(s)	7 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.39
Penumbra	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88

Is ZBH or PEN more profitable?

Penumbra has a net margin of 11.54% compared to Zimmer Biomet's net margin of 10.51%. Zimmer Biomet's return on equity of 12.76% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	10.51%	12.76%	7.21%
Penumbra	11.54%	11.55%	8.76%

Does the media refer more to ZBH or PEN?

In the previous week, Zimmer Biomet had 4 more articles in the media than Penumbra. MarketBeat recorded 16 mentions for Zimmer Biomet and 12 mentions for Penumbra. Penumbra's average media sentiment score of 1.43 beat Zimmer Biomet's score of 1.16 indicating that Penumbra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	13 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	10 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings and valuation, ZBH or PEN?

Zimmer Biomet has higher revenue and earnings than Penumbra. Zimmer Biomet is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$7.83B	2.55	$903.70M	$4.11	24.55
Penumbra	$1.28B	8.03	$14.01M	$3.76	70.10

Which has more volatility and risk, ZBH or PEN?

Zimmer Biomet has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500.

Summary

Penumbra beats Zimmer Biomet on 10 of the 17 factors compared between the two stocks.